Skip to content

XENE

Xenon Pharmaceuticals Inc.

Key figures

MetricLast 12 months5-year CAGR
Revenue$0−25.3%
Operating income−$465M—
Net income−$429M—
EPS−$4.70—
Free cash flow−$357M—